XJPX
4202
Market cap2.33bUSD
Oct 09, Last price
1,458.00JPY
1D
1.25%
1Q
3.96%
Jan 2017
13.02%
Name
Daicel Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Daicel Corporation, a globally active company founded in Osaka, Japan, in 1919, operates across diverse sectors including medical/healthcare, smart technologies, safety solutions, advanced materials, and engineering plastics. Its extensive product range serves various industries across Japan, China, and international markets. The company provides cosmetic ingredients like 1,3-Butylene glycol and polyglycerin, alongside specialized chiral and achiral columns, analytical tools, reagents, and comprehensive services for analysis, purification, and synthesis. For the electronics industry, Daicel offers high-performance films, solvents for electronic materials, resist polymers, semiconductor cleaning agents, optical components, silver nanoparticle inks, and organic semiconductor devices. In safety applications, their portfolio includes inflators, pyro-fuses, and safety devices designed for non-mobility products. They also manufacture a wide array of chemical products such as acetic acid and its derivatives, cellulose acetate, cycloaliphatic epoxies, and caprolactone. Additionally, Daicel contributes to the health and wellness sector with nutraceuticals like ceramide from konjac root, equol from soybeans, and specialized supplement formulations such as DiSPERZiSTA. Their offerings further encompass engineering plastics, high-performance polymers, functional sheets, and packaging films, alongside advanced water treatment systems like UF membrane modules and ultra-fine bubble diffusers. These innovative products are vital for applications in transportation, electronics, medical care, personal care, daily life, and environmental and energy management. Formerly known as Daicel Chemical Industries, Ltd., the company adopted its current name in October 2011.
Related entities
Subsidiaries
Daicel Miraizu Ltd.
Key people
Yoshimi Ogawa
Chairman of the Board · since 2025
Yasuhiro Sakaki
President, Executive President, Chief Executive Officer, Representative Director · since 2025
Takashi Miyamoto
Senior Managing Executive Officer, Chief Director of Performance Materials, President of Subsidiary · since 2024
Hiroshi Iwase
Managing Executive Officer, Manager of Smart SBU, President of Subsidiary · since 2024
Kazuya Kurosawa
Managing Executive Officer, Manager of Material SBU, Manager of Chemical BU in Material SBU, President of Subsidiary · since 2025
Yoichi Nemoto
Managing Executive Officer, Deputy Chief Director of Business Support, Senior Director of Group Governance & Finance in Main Business Support Unit · since 2025
Seiji Sakano
Managing Executive Officer, Manager of Life Science SBU · since 2024
Hitoshi Hayashi
Executive Officer, Deputy Chief Director of Assessment, Manager of Assessment Promotion Office · since 2022
Masahiko Hirokawa
Executive Officer, Deputy Chief Director of Business Support, Leader of IR & Public Relations Group in Main Business Support Unit, Manager in Sustainable Management Promotion Office · since 2024
Yosuke Omae
Executive Officer, Chief Director of Global Audit in Safety SBU, Harima Plant Manager · since 2025
Eiichi Ryobo
Executive Officer, Manager of Safety SBU, Chairman & Chairperson of Subsidiaries · since 2024
Takaharu Takikawa
Executive Officer, Manager of Engineering Center · since 2021
Ryohei Yamada
Executive Officer, Director of Medical Business Development in Life Science SBU, Assistant Manager of Life Science SBU · since 2023
Naotaka Kawaguchi
Senior Managing Executive Officer, Chief Director of Technology, Director · since 2024
Toshio Shiwaku
Senior Managing Executive Officer, Chief Director of Assessment, Chief Director of Research and Development, Director · since 2024
Kotaro Sugimoto
Senior Managing Executive Officer, Chief Director of Business Support, Representative Director · since 2020
Independent Director · since 2019
Takeshi Furuichi
Independent Director · since 2020
Independent Director · since 2018
Independent Director · since 2025
Headquarters & legal address
大深町3番1号
大阪府 大阪市北区 530-0011
JP
大阪府 大阪市北区 530-0011
JP
Address
3-1, Ofuka-cho
Kita-ku, Osaka Osaka 530-0011
JP
Kita-ku, Osaka Osaka 530-0011
JP
Other language
Daicel Corporation
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||